1. Ferrous sulfate supplementation harmful in nonanaemic pregnancy

   Clinical study 19 January 2013 Pages: 1 - 1

2. Labelling changes for cimicifuga in Australia

   News item 19 January 2013 Pages: 2 - 2

3. Alerts from Health Canada about adulteration of herbal medicines

   News item 19 January 2013 Pages: 2 - 2

4. FDA's New Risk Communication Advisory Committee

   Media release 19 January 2013 Pages: 2 - 2

5. Myocarditis reported with clozapine

   News item 19 January 2013 Pages: 3 - 3

6. ADRAC has received 36 reports of mirtazapine-related blood dyscrasias since 2001

   News item 19 January 2013 Pages: 3 - 3

7. “Moderate safety advantage” with oxycodone over morphine

   Clinical study 19 January 2013 Pages: 3 - 3

8. The pharmacokinetics (PK) and toxicity of methotrexate are different in very young infants

   Clinical study 19 January 2013 Pages: 3 - 3

9. Zelmac [tegaserod] is to be withdrawn from the Swiss market

   Media release 19 January 2013 Pages: 3 - 3

10. The sweet and sour RECORD of rosiglitazone for type 2 diabetes

    News item 19 January 2013 Pages: 4 - 4

11. GSK goes on RECORD regarding rosiglitazone

    Correspondence 19 January 2013 Pages: 5 - 5

12. GSK updates Avandia label for Canada

    News item 19 January 2013 Pages: 5 - 5

13. GlaxoSmithKline (GSK) has issued a Health Canada-endorsed public communication addressing public concerns about safety of Avandia

    Media release 19 January 2013 Pages: 5 - 5

14. Albendazole/mebendazole

    Case report 19 January 2013 Pages: 6 - 6

15. Aluminum hydroxide/calcium carbonate/magnesium hydroxide

    Case report 19 January 2013 Pages: 6 - 6

16. Adalimumab

    Case report 19 January 2013 Pages: 6 - 6

17. Alemtuzumab/fludarabine/melphalan

    Case report 19 January 2013 Pages: 6 - 6

18. Botulinum toxin A

    Case report 19 January 2013 Pages: 7 - 7

19. Anakinra

    Case report 19 January 2013 Pages: 7 - 7

20. Cytarabine/pegaspargase

    Case report 19 January 2013 Pages: 8 - 8

21. Cytarabine

    Case report 19 January 2013 Pages: 8 - 8

22. Cefazolin/ceftriaxone

    Case report 19 January 2013 Pages: 8 - 8

23. Dipyrone

    Case report 19 January 2013 Pages: 9 - 9

24. Edaravone

    Case report 19 January 2013 Pages: 9 - 9

25. Dexfenfluramine/fenfluramine

    Case report 19 January 2013 Pages: 9 - 9

26. Eperisone overdose

    Case report 19 January 2013 Pages: 10 - 10

27. Erlotinib

    Case report 19 January 2013 Pages: 10 - 10

28. Eptacog alfa

    Case report 19 January 2013 Pages: 10 - 10

29. Eucalyptus

    Case report 19 January 2013 Pages: 11 - 11

30. Filgrastim

    Case report 19 January 2013 Pages: 11 - 11

31. Fentanyl/ropivacaine/sufentanil

    Case report 19 January 2013 Pages: 11 - 11

32. Hydroxychloroquine

    Case report 19 January 2013 Pages: 12 - 12

33. Imatinib

    Case report 19 January 2013 Pages: 12 - 12

34. Infliximab

    Case report 19 January 2013 Pages: 12 - 12

35. Herbal medicines

    Case report 19 January 2013 Pages: 12 - 12

36. Linezolid

    Case report 19 January 2013 Pages: 13 - 13

37. Low molecular weight heparins

    Case report 19 January 2013 Pages: 13 - 13

38. Methadone interaction

    Case report 19 January 2013 Pages: 14 - 14

39. Methadone

    Case report 19 January 2013 Pages: 14 - 14

40. Mitotane

    Case report 19 January 2013 Pages: 14 - 14

41. Paracetamol

    Case report 19 January 2013 Pages: 14 - 15

42. Quinidine

    Case report 19 January 2013 Pages: 15 - 15

43. Poliovirus vaccine live oral

    Case report 19 January 2013 Pages: 15 - 15

44. Peginterferon α-2b/ribavirin

    Case report 19 January 2013 Pages: 15 - 15

45. Risperidone interaction

    Case report 19 January 2013 Pages: 16 - 16

46. Sirolimus

    Case report 19 January 2013 Pages: 16 - 16

47. Salbutamol/terbutaline

    Case report 19 January 2013 Pages: 16 - 16

48. Teucrium polium

    Case report 19 January 2013 Pages: 17 - 17

49. Sunitinib

    Case report 19 January 2013 Pages: 17 - 17

50. Sotalol

    Case report 19 January 2013 Pages: 17 - 17